329 related articles for article (PubMed ID: 28501249)
21. Efforts to improve local control in rectal cancer compromise survival by the potential morbidity of optimal mesorectal excision.
Laurent C; Nobili S; Rullier A; Vendrely V; Saric J; Rullier E
J Am Coll Surg; 2006 Nov; 203(5):684-91. PubMed ID: 17084330
[TBL] [Abstract][Full Text] [Related]
22. Current Status of the Management of Stage I Rectal Cancer.
Olson CH
Curr Oncol Rep; 2020 Apr; 22(4):40. PubMed ID: 32240411
[TBL] [Abstract][Full Text] [Related]
23. Locally advanced rectal cancer: the importance of a multidisciplinary approach.
Berardi R; Maccaroni E; Onofri A; Morgese F; Torniai M; Tiberi M; Ferrini C; Cascinu S
World J Gastroenterol; 2014 Dec; 20(46):17279-87. PubMed ID: 25516638
[TBL] [Abstract][Full Text] [Related]
24. Preclinical cadaveric study of transanal robotic proctectomy with total mesorectal excision combined with laparoscopic assistance.
Gomez Ruiz M; Martin Parra I; Calleja Iglesias A; Stein H; Sprinkle S; Manuel Palazuelos C; Alonso Martin J; Cagigas Fernandez C; Castillo Diego J; Gomez Fleitas M
Int J Med Robot; 2015 Jun; 11(2):188-93. PubMed ID: 24574007
[TBL] [Abstract][Full Text] [Related]
25. Comparison of Transanal Endoscopic Microsurgery and Total Mesorectal Excision in the Treatment of T1 Rectal Cancer: A Meta-Analysis.
Lu JY; Lin GL; Qiu HZ; Xiao Y; Wu B; Zhou JL
PLoS One; 2015; 10(10):e0141427. PubMed ID: 26505895
[TBL] [Abstract][Full Text] [Related]
26. The Rationale for Transanal Total Mesorectal Excision.
Motson RW; Lacy A
Dis Colon Rectum; 2015 Sep; 58(9):911-3. PubMed ID: 26252855
[No Abstract] [Full Text] [Related]
27. Multimodality management of locally advanced rectal cancer.
Moore HG; Guillem JG
Am Surg; 2003 Jul; 69(7):612-9. PubMed ID: 12889627
[TBL] [Abstract][Full Text] [Related]
28. Advances and challenges in treatment of locally advanced rectal cancer.
Smith JJ; Garcia-Aguilar J
J Clin Oncol; 2015 Jun; 33(16):1797-808. PubMed ID: 25918296
[TBL] [Abstract][Full Text] [Related]
29. [Transanal endocopic microsurgery (TEM) in advanced rectal cancer disease treatment].
Paci M; Scoglio D; Ursi P; Barchetti L; Fabiani B; Ascoli G; Lezoche G
Ann Ital Chir; 2010; 81(4):269-74; discussion 283. PubMed ID: 21322272
[TBL] [Abstract][Full Text] [Related]
30. [Transition of treatment strategy for locally advanced rectal cancer towards "watch and wait"].
Xiao WW; Chen G
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jun; 22(6):514-520. PubMed ID: 31238631
[TBL] [Abstract][Full Text] [Related]
31. Total mesorectal excision in the treatment of rectal cancer: a review.
Ceelen W; Pattyn P
Acta Chir Belg; 2000; 100(3):94-9. PubMed ID: 11280182
[TBL] [Abstract][Full Text] [Related]
32. [Management of early rectal cancer: total mesorectal excision versus transanal resection?].
Ris F; Buchs NC; Hompes R; Morel P
Rev Med Suisse; 2013 Jun; 9(391):1294-8. PubMed ID: 23875257
[TBL] [Abstract][Full Text] [Related]
33. Transanal TAMIS total mesorectal excision (TME)--a work in progress.
Wexner SD; Berho M
Tech Coloproctol; 2014 May; 18(5):423-5. PubMed ID: 24682802
[No Abstract] [Full Text] [Related]
34. Transanal minimally invasive surgery for total mesorectal excision.
Atallah S
Minim Invasive Ther Allied Technol; 2014 Jan; 23(1):10-6. PubMed ID: 23992386
[TBL] [Abstract][Full Text] [Related]
35. A perspective on the current treatment strategies for locally advanced rectal cancer.
Avallone A; Aloj L; Aprile G; Rosati G; Budillon A
Int J Biochem Cell Biol; 2015 Aug; 65():192-6. PubMed ID: 26055517
[TBL] [Abstract][Full Text] [Related]
36. Total Neoadjuvant Therapy for Rectal Cancer.
Affleck AG; Herzig D
Surg Clin North Am; 2024 Jun; 104(3):609-617. PubMed ID: 38677824
[TBL] [Abstract][Full Text] [Related]
37. Surgical management of rectal cancer.
Rajput A; Bullard Dunn K
Semin Oncol; 2007 Jun; 34(3):241-9. PubMed ID: 17560986
[TBL] [Abstract][Full Text] [Related]
38. The Drive Toward Transanal Total Mesorectal Excision - Science or Rhetoric?
Warren OJ; Solomon MJ
Dis Colon Rectum; 2015 Sep; 58(9):909-10. PubMed ID: 26252854
[No Abstract] [Full Text] [Related]
39. [Local recurrence and survival rate after rectal cancer operations and multimodal therapy].
Thomschke D; Kyau-Ummen B; Halbfass HJ
Chirurg; 2002 Mar; 73(3):245-54. PubMed ID: 11963499
[TBL] [Abstract][Full Text] [Related]
40. Organ Preservation in Rectal Adenocarcinoma: a phase II randomized controlled trial evaluating 3-year disease-free survival in patients with locally advanced rectal cancer treated with chemoradiation plus induction or consolidation chemotherapy, and total mesorectal excision or nonoperative management.
Smith JJ; Chow OS; Gollub MJ; Nash GM; Temple LK; Weiser MR; Guillem JG; Paty PB; Avila K; Garcia-Aguilar J;
BMC Cancer; 2015 Oct; 15():767. PubMed ID: 26497495
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
